| William Edson Campos, CRNA | |
|
2401 S 31st St # Msarm200, Temple, TX 76508-7167 | |
| (254) 215-9790 | |
| Not Available |
| Full Name | William Edson Campos |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 16 Years |
| Location | 2401 S 31st St # Msarm200, Temple, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063651271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 713222 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978610 PECOS PAC ID: 7315907128 Enrollment ID: O20041015000685 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Entity Name | Southwest Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548540594 PECOS PAC ID: 7416123518 Enrollment ID: O20111220000303 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477066405 PECOS PAC ID: 2365701737 Enrollment ID: O20180110000102 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Entity Name | Northstar Anesthesia Iii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356968952 PECOS PAC ID: 0042630501 Enrollment ID: O20201022000080 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Edson Campos, CRNA Po Box 844658, Dallas, TX 75284-4658 Ph: (800) 994-0371 | William Edson Campos, CRNA 2401 S 31st St # Msarm200, Temple, TX 76508-7167 Ph: (254) 215-9790 |
News Archive
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.
Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.
Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 2 clinical study of STA-9090 in non-small cell lung cancer (NSCLC).
› Verified 1 days ago
Mr. Nicholas Grant Smith, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76504 Phone: 254-724-2111 | |
John Murphy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Mrs. Sherilyn Kaye Medina, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Justin Robert Anders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Joshua Joseph Philippon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 Fax: 254-724-7603 | |
Clarence E. Grunden, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1905 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-298-2682 Fax: 254-778-7197 | |
Maelen Bernasor, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 |